GPT and metabolic dysfunction-associated steatotic liver disease: Abundant studies and clinical practices have proven that the liver enzyme levels such as ALT and so on were increased usually in the NAFLD patients, and these liver enzymes could be used as the diagnostic markers for the NAFLD at some extent [29–31].